Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade
Lisa Cucolo, Qingzhou Chen, Jingya Qiu, et al.
Immunity (2022) Vol. 55, Iss. 4, pp. 671-685.e10
Open Access | Times Cited: 62

Showing 26-50 of 62 citing articles:

Targeted protein degradation with small molecules for cancer immunotherapy
Zichao Yang, Jianwei Xu, Xixiang Yang, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101058-101058
Open Access
FGFR1/MAPK-directed brachyury activation drives PD-L1-mediated immune evasion to promote lung cancer progression
Yunping Hu, Yong Lu, Fei Xing, et al.
Cancer Letters (2022) Vol. 547, pp. 215867-215867
Closed Access | Times Cited: 16
The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway
Shuizhong Cen, Xiaojie Peng, Jianwen Deng, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 3, pp. 375-388
Open Access | Times Cited: 10
The dichotomic role of single cytokines: Fine-tuning immune responses
Rafael Cardoso Maciel Costa Silva, Leonardo Holanda Travassos, Fabiano Ferreira
Cytokine (2023) Vol. 173, pp. 156408-156408
Closed Access | Times Cited: 10
Necroptosis in immunity, tissue homeostasis, and cancer
Jinwen Yin, Yuqiang Yu, Xinyue Huang, et al.
Current Opinion in Immunology (2024) Vol. 89, pp. 102455-102455
Closed Access | Times Cited: 3
Development of a First-in-Class RIPK1 Degrader to Enhance Antitumor Immunity
Xin Yu, Dong Lu, Xiaoli Qi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Deciphering the interplay of HPV infection, MHC-II expression, and CXCL13+ CD4+ T cell activation in oropharyngeal cancer: implications for immunotherapy
Shida Yan, Xing Zhang, Qiaohong Lin, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 10
Open Access | Times Cited: 2
Syndecan-1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy
Yun Liu, Chen Xu, Li Zhang, et al.
Science Advances (2024) Vol. 10, Iss. 37
Open Access | Times Cited: 2
Overcoming Resistance Mechanisms to Melanoma Immunotherapy
David X. Zheng, David J. Bozym, Giuseppe Tarantino, et al.
American Journal of Clinical Dermatology (2024)
Closed Access | Times Cited: 2
Development of a RIPK1 degrader to enhance antitumor immunity
Xin Yu, Dong Lu, Xiaoli Qi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus
Rafael Cardoso Maciel Costa Silva, Marcela F. Lopes, Leonardo Holanda Travassos
Cancer Pathogenesis and Therapy (2022) Vol. 1, Iss. 1, pp. 76-86
Open Access | Times Cited: 10
RIPK1 is aberrantly expressed in multiple B-cell cancers and implicated in the underlying pathogenesis
Baoyu Wu, Jingyu Li, Han Wang, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 5
hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC
Paola Trono, Annalisa Tocci, Belinda Palermo, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 8, pp. e006913-e006913
Open Access | Times Cited: 5
Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors
Sarah E. Fenton, Μαρκέλλα Ζαννίκου, Liliana Ilut, et al.
Molecular Cancer Research (2022) Vol. 21, Iss. 4, pp. 332-344
Open Access | Times Cited: 8
Breaking the mold: Overcoming resistance to immune checkpoint inhibitors
Menglu Zhao, Chunyan Yan, Ya-Nan Wei, et al.
Antiviral Research (2023) Vol. 219, pp. 105720-105720
Closed Access | Times Cited: 4
Development of a First-in-Class RIPK1 Degrader to Enhance Antitumor Immunity
Jin Wang, Dong Lu, Xin Yu, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy
Monika Ryba‐Stanisławowska
Cellular Oncology (2024)
Open Access | Times Cited: 1
TBK1 inhibition unleashes RIPK1, resensitizing tumors to immunotherapy
Michelle A. Kelliher, Katherine A. Fitzgerald
Trends in Immunology (2023) Vol. 44, Iss. 3, pp. 156-158
Closed Access | Times Cited: 3
Implications of inflammatory cell death-related IFNG and co-expressed RNAs (AC006369.1 and CCR7) in breast carcinoma prognosis, and anti-tumor immunity
Yongran Deng, Zhenlong Li, Mingmei Pan, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 3
Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy
Il‐Kyu Kim, Mark S. Diamond, Salina Yuan, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Single-cell RNA sequencing reveals distinct tumor microenvironment of ground glass nodules and solid nodules in lung adenocarcinoma
Xiaofeng Huang, Zhi‐Meng Lu, Xuewei Jiang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 2
Receptor-interacting protein kinase 2 is associated with tumor immune infiltration, immunotherapy-related biomarkers, and affects gastric cancer cells growth in vivo
Qian Yang, Kunqiao Hong, Li Yu, et al.
Journal of Cancer (2023) Vol. 15, Iss. 1, pp. 176-191
Open Access | Times Cited: 2
Single-cell CRISPR immune screens reveal immunological roles of tumor intrinsic factors
Jiakai Hou, Shaoheng Liang, Chunyu Xu, et al.
NAR Cancer (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 4
Prediction Model for Therapeutic Responses in Ovarian Cancer Patients using Paclitaxel-resistant Immune-related lncRNAs
Xin Li, Huiqiang Liu, Fanchen Wang, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 26, pp. 4213-4231
Open Access
Steroidal saponins: Natural compounds with the potential to reverse tumor drug resistance (Review)
Aiping Cui, Hai Liu, Xiaoxuan Liu, et al.
Oncology Letters (2024) Vol. 28, Iss. 6
Open Access

Scroll to top